Jump to content

Welcome to Sclero Forums!! How may we help you?


Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE).


  • Please log in to reply
No replies to this topic

#1 Joelf


    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,845 posts
  • Location:West Sussex

Posted 11 February 2014 - 01:44 PM

Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE).


A decreased mortality risk was seen with the prescription of antiplatelet therapy and the time period in which NPSLE was diagnosed did not significantly influence survival. PubMed, Lupus, 2013 Nov 15. (Also see: Systemic Lupus Erythematosus Symptoms)


This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Jo Frowde
ISN Assistant Webmaster
SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)